204 related articles for article (PubMed ID: 28854447)
1. Prenatal Therapy with Magnesium Sulfate and Its Correlation with Neonatal Serum Magnesium Concentration.
García Alonso L; Pumarada Prieto M; González Colmenero E; Concheiro Guisán A; Suárez Albo M; Durán Fernández-Feijoo C; González Durán L; Fernández Lorenzo JR
Am J Perinatol; 2018 Jan; 35(2):170-176. PubMed ID: 28854447
[TBL] [Abstract][Full Text] [Related]
2. [Prenatal treatment with magnesium sulphate: Initial clinical outcomes in pre-term infants less than 29 weeks and correlation with neonatal magnesium levels].
García Alonso L; Pumarada Prieto M; González Colmenero E; Concheiro Guisán A; Suárez Albo M; Durán Fernández-Feijoo C; González Durán L; Fernández Lorenzo JR
An Pediatr (Barc); 2017 Mar; 86(3):135-141. PubMed ID: 27282203
[TBL] [Abstract][Full Text] [Related]
3. Impact of dosing schedule on uptake of neuroprotective magnesium sulfate.
Cuff RD; Sullivan SA; Chang EY
J Matern Fetal Neonatal Med; 2020 Mar; 33(6):982-986. PubMed ID: 30122071
[No Abstract] [Full Text] [Related]
4. Influence of antenatal magnesium sulfate application on cord blood levels of brain-derived neurotrophic factor in premature infants.
Bachnas MA; Mose JC; Effendi JS; Andonotopo W
J Perinat Med; 2014 Jan; 42(1):129-34. PubMed ID: 24062546
[TBL] [Abstract][Full Text] [Related]
5. Magnesium sulfate, chorioamnionitis, and neurodevelopment after preterm birth.
Kamyar M; Manuck TA; Stoddard GJ; Varner MW; Clark E
BJOG; 2016 Jun; 123(7):1161-6. PubMed ID: 26036660
[TBL] [Abstract][Full Text] [Related]
6. Antenatal magnesium sulfate for both tocolysis and fetal neuroprotection in premature rupture of the membranes before 32 weeks' gestation.
Jung EJ; Byun JM; Kim YN; Lee KB; Sung MS; Kim KT; Shin JB; Jeong DH
J Matern Fetal Neonatal Med; 2018 Jun; 31(11):1431-1441. PubMed ID: 28391733
[TBL] [Abstract][Full Text] [Related]
7. Immediate clinical outcomes in preterm neonates receiving antenatal magnesium for neuroprotection.
Basu SK; Chickajajur V; Lopez V; Bhutada A; Pagala M; Rastogi S
J Perinat Med; 2011 Aug; 40(2):185-9. PubMed ID: 21834608
[TBL] [Abstract][Full Text] [Related]
8. Maternal obesity and neuroprotective magnesium sulfate.
McPherson J; Smiley S; Stamilio D
Am J Obstet Gynecol; 2015 Oct; 213(4):582.e1-6. PubMed ID: 26116874
[TBL] [Abstract][Full Text] [Related]
9. Association of duration of neuroprotective magnesium sulfate infusion with neonatal and maternal outcomes.
McPherson JA; Rouse DJ; Grobman WA; Palatnik A; Stamilio DM
Obstet Gynecol; 2014 Oct; 124(4):749-755. PubMed ID: 25198275
[TBL] [Abstract][Full Text] [Related]
10. Magnesium sulphate and perinatal mortality and morbidity in very-low-birthweight infants born between 24 and 32 weeks of gestation in Japan.
Ohhashi M; Yoshitomi T; Sumiyoshi K; Kawagoe Y; Satoh S; Sameshima H; Ikenoue T
Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():140-5. PubMed ID: 27131232
[TBL] [Abstract][Full Text] [Related]
11. Maternal magnesium therapy, neonatal serum magnesium concentration and immediate neonatal outcomes.
Narasimhulu D; Brown A; Egbert NM; Rojas M; Haberman S; Bhutada A; Minkoff H; Rastogi S
J Perinatol; 2017 Dec; 37(12):1297-1303. PubMed ID: 28981078
[TBL] [Abstract][Full Text] [Related]
12. Antenatal magnesium sulfate and neuroprotection.
Doyle LW
Curr Opin Pediatr; 2012 Apr; 24(2):154-9. PubMed ID: 22227787
[TBL] [Abstract][Full Text] [Related]
13. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.
Crowther CA; Hiller JE; Doyle LW; Haslam RR;
JAMA; 2003 Nov; 290(20):2669-76. PubMed ID: 14645308
[TBL] [Abstract][Full Text] [Related]
14. Effects and Safety of Magnesium Sulfate on Neuroprotection: A Meta-analysis Based on PRISMA Guidelines.
Zeng X; Xue Y; Tian Q; Sun R; An R
Medicine (Baltimore); 2016 Jan; 95(1):e2451. PubMed ID: 26735551
[TBL] [Abstract][Full Text] [Related]
15. Does magnesium exposure affect neonatal resuscitation?
Drassinower D; Friedman AM; Levin H; Običan SG; Gyamfi-Bannerman C
Am J Obstet Gynecol; 2015 Sep; 213(3):424.e1-5. PubMed ID: 26026919
[TBL] [Abstract][Full Text] [Related]
16. Maternal and fetal serum concentrations of magnesium after administration of a 6-g bolus dose of magnesium sulfate (MgSO
Jonsdotter A; Rocha-Ferreira E; Hagberg H; Carlsson Y
Acta Obstet Gynecol Scand; 2022 Aug; 101(8):856-861. PubMed ID: 35501953
[TBL] [Abstract][Full Text] [Related]
17. Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial.
Wolf HT; Brok J; Henriksen TB; Greisen G; Salvig JD; Pryds O; Hedegaard M; Weber T; Hegaard HK; Pinborg A; Huusom LD;
BJOG; 2020 Sep; 127(10):1217-1225. PubMed ID: 32237024
[TBL] [Abstract][Full Text] [Related]
18. School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo.
Doyle LW; Anderson PJ; Haslam R; Lee KJ; Crowther C;
JAMA; 2014 Sep; 312(11):1105-13. PubMed ID: 25226476
[TBL] [Abstract][Full Text] [Related]
19. Timing of administration of antenatal magnesium sulfate and umbilical cord blood magnesium levels in preterm babies.
Reynolds A; Slattery S; Byrne S; Neary E; Müllers S; Kent E; Malone FD; El-Khuffash A; McGarvey C; Hayes BC
J Matern Fetal Neonatal Med; 2019 Mar; 32(6):1014-1019. PubMed ID: 29082790
[TBL] [Abstract][Full Text] [Related]
20. What we learned about the role of antenatal magnesium sulfate for the prevention of cerebral palsy.
Rouse DJ; Hirtz D;
Semin Perinatol; 2016 Aug; 40(5):303-6. PubMed ID: 27117179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
